Portfolio (Quarterly)
Guide ↗
Nierenberg Investment Management Company, LLC
· CIK 0001282683| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CRTO | CRITEO S A | Communication Services | 1,052,787.0 | $18.9M | 9.37% | +164K | +18.4% | $17.93 | -1.4% |
| 2 | LYFT | LYFT INC | Technology | 1,295,623.0 | $17.2M | 8.55% | +482K | +59.2% | $13.30 | +2.9% |
| 3 | KBR | KBR INC | Industrials | 386,443.0 | $14.2M | 7.07% | +313K | +424.3% | $36.86 | -10.1% |
| 4 | GLRE | GREENLIGHT CAPITAL RE LTD | Financial Services | 102,510.0 | $1.8M | 0.88% | +47K | +84.5% | $17.29 | -5.5% |
| 5 | FCN | FTI CONSULTING INC | Industrials | 9,780.0 | $1.7M | 0.86% | +225.0 | +2.4% | $176.77 | -13.4% |
| 6 | TNDM | TANDEM DIABETES CARE INC | Healthcare | 79,510.0 | $1.5M | 0.76% | +35K | +78.5% | $19.17 | -23.1% |
| 7 | TTGT | TECHTARGET INC | Communication Services | 202,910.0 | $787K | 0.39% | +66K | +48.2% | $3.88 | +21.2% |
| 8 | FORR | FORRESTER RESH INC | Industrials | 131,110.0 | $742K | 0.37% | +120K | +1034.7% | $5.66 | +20.0% |
| 9 | HOPE | HOPE BANCORP INC | Financial Services | 63,555.0 | $710K | 0.35% | +51K | +406.2% | $11.17 | +11.9% |
| 10 | TTEC | TTEC HLDGS INC | Technology | 255,555.0 | $639K | 0.32% | +200K | +360.0% | $2.50 | +5.8% |
| 11 | OSUR | ORASURE TECHNOLOGIES INC | Healthcare | 55,555.0 | $167K | 0.08% | +11K | +24.7% | $3.00 | +37.2% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Energy
24.8%
Financial Services
17.2%
Technology
16.6%
Communication Services
13.8%
Industrials
12.8%
Consumer Cyclical
7.9%
Healthcare
4.8%
Real Estate
2.1%